Coumarin sulfonamides derivatives as potent and selective COX-2 inhibitors with efficacy in suppressing cancer proliferation and metastasis

被引:73
作者
Lu, Xiao-Yuan [1 ]
Wang, Zhong-Chang [1 ]
Ren, Shen-Zhen [1 ]
Shen, Fa-Qian [1 ]
Man, Ruo-Jun [1 ]
Zhu, Hai-Liang [1 ]
机构
[1] Nanjing Univ, State Key Lab Pharmaceut Biotechnol, Nanjing 210023, Jiangsu, Peoples R China
关键词
Coumarin; Sulfonamides; COX-2; inhibitor; Anticancer; Docking simulation; CELLS; CYCLOOXYGENASE-2; INFLAMMATION; ACIDS;
D O I
10.1016/j.bmcl.2016.06.037
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
Cyclooxygenase-2 is frequently overexpression in malignant tumors and the product PGE(2) promotes cancer cell progression and metastasis. We designed novel series of coumarin sulfonamides derivatives to improve biological activities of COX-2 inhibition and anticancer. Among them, compound 7t showed most powerful selective inhibitory and antiproliferative activity (IC50 = 0.09 mu M for COX-2, IC50 = 48.20 mu M for COX-1, IC50 = 0.36 mu M against HeLa cells), comparable to the control positive compound Celecoxib (0.31 mu M, 43.37 mu M, 7.79 mu M). Cancer cell apoptosis assay were performed and results indicated that compound 7t effectively fuels HeLa cells apoptosis in a dose and time-dependent manner. Moreover, 7t could significantly suppress cancer cell adhesion, migration and invasion which were essential process of cancer metastasis. Docking simulations results was further indicated that compound 7t could bind well to the COX-2 active site and guided a reasonable design of selective COX-2 inhibitor with anticancer activities in future. (C) 2016 Elsevier Ltd. All rights reserved.
引用
收藏
页码:3491 / 3498
页数:8
相关论文
共 29 条
  • [1] Smoldering and polarized inflammation in the initiation and promotion of malignant disease
    Balkwill, F
    Charles, KA
    Mantovani, A
    [J]. CANCER CELL, 2005, 7 (03) : 211 - 217
  • [2] Cyclooxygenase-2 inhibitors. 1,5-diarylpyrrol-3-acetic esters with enhanced inhibitory activity toward cyclooxygenase-2 and improved cyclooxygenase-2/cyclooxygenase-1 selectivity
    Biava, Mariangela
    Porretta, Giulio Cesare
    Poce, Giovanna
    Supino, Sibilla
    Forli, Stefano
    Rovini, Michele
    Cappelli, Andrea
    Manetti, Fabrizio
    Botta, Maurizio
    Sautebin, Lidia
    Rossi, Antonietta
    Pergola, Carlo
    Ghelardini, Carla
    Vivoli, Elisa
    Makovec, Francesco
    Anzellotti, Paola
    Patrignani, Paola
    Anzini, Maurizio
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (22) : 5403 - 5411
  • [3] Neutralizing Tumor-Promoting Chronic Inflammation: A Magic Bullet?
    Coussens, Lisa M.
    Zitvogel, Laurence
    Palucka, A. Karolina
    [J]. SCIENCE, 2013, 339 (6117) : 286 - 291
  • [4] Antiproliferative and Antimigratory Actions of Synthetic Long Chain n-3 Monounsaturated Fatty Acids in Breast Cancer Cells That Overexpress Cyclooxygenase-2
    Cui, Pei H.
    Rawling, Tristan
    Bourget, Kirsi
    Kim, Terry
    Duke, Colin C.
    Doddareddy, Munikumar R.
    Hibbs, David E.
    Zhou, Fanfan
    Tattam, Bruce N.
    Petrovic, Nenad
    Murray, Michael
    [J]. JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (16) : 7163 - 7172
  • [5] The gastrointestinal safety and effect on disease activity of etoricoxib, a selective Cox-2 inhibitor in inflammatory bowel diseases
    El Miedany, Y
    Youssef, S
    Ahmed, I
    El Gaafary, M
    [J]. AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (02) : 311 - 317
  • [6] Design, synthesis, and biological evaluation of substituted hydrazone and pyrazole derivatives as selective COX-2 inhibitors: Molecular docking study
    El-Sayed, Magda A. -A.
    Abdel-Aziz, Naglaa I.
    Abdel-Aziz, Alaa A. -M.
    El-Azab, Adel S.
    Asiri, Yousif A.
    ElTahir, Kamal E. H.
    [J]. BIOORGANIC & MEDICINAL CHEMISTRY, 2011, 19 (11) : 3416 - 3424
  • [7] Targeting prostaglandin E EP receptors to inhibit metastasis
    Fulton, Amy M.
    Ma, Xinrong
    Kundu, Namita
    [J]. CANCER RESEARCH, 2006, 66 (20) : 9794 - 9797
  • [8] RETRACTED: MIG-7 Controls COX-2/PGE2-Mediated Lung Cancer Metastasis (Retracted article. See vol. 79, pg. 4553, 2019)
    Ho, Ming-Yi
    Liang, Shu-Mei
    Hung, Shao-Wen
    Liang, Chi-Ming
    [J]. CANCER RESEARCH, 2013, 73 (01) : 439 - 449
  • [9] Prostaglandin E2 regulates tumor angiogenesis in prostate cancer
    Jain, Shalini
    Chakraborty, Goutam
    Raja, Remya
    Kale, Smita
    Kundu, Gopal C.
    [J]. CANCER RESEARCH, 2008, 68 (19) : 7750 - 7759
  • [10] Konturek SJ, 2005, J PHYSIOL PHARMACOL, V56, P507